Metal Hydrogen Carriers Show Promise for Cancer and Inflammation Treatment
- Authors
- Ao Li, Tingting Cao, Lili Feng, Yaoyu Hu, Yaofeng Zhou, Piaoping Yang
- Journal
- ACS Applied Materials & Interfaces
- Year
- 2024
- DOI
- 10.1021/acsami.3c16668
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
TL;DR
Scientists found that tiny metal particles loaded with hydrogen could fight diseases like cancer and inflammation better than old-fashioned medicines, because hydrogen is really good at cleaning up harmful stuff in your body—but researchers still need to figure out how to make them work better and easier to produce.
Key Finding
Metal hydrides show promise as a way to deliver hydrogen for disease treatment, potentially offering better safety and selectivity than traditional antioxidant therapies, though significant technical hurdles remain before clinical use.
Summary
This review examines how metal hydrides—materials that can store and release hydrogen—might be used to treat diseases like cancer and inflammatory conditions. Hydrogen can neutralize harmful molecules in the body called reactive oxygen species, and metal hydrides could potentially deliver hydrogen more effectively than current treatments. However, the field is still early, with challenges including difficulty targeting specific areas of the body and complex manufacturing processes.
Practical Takeaway
This is a review article summarizing early-stage research on metal hydrides rather than a completed study with results. No human trials have been conducted, and the authors themselves note major limitations in current approaches. Anyone interested in hydrogen-based therapies should recognize this represents theoretical potential, not proven treatments.
Abstract
In comparison to traditional antioxidant treatment methods, the use of hydrogen to eliminate reactive oxygen species from the body has the advantages of high biological safety, strong selectivity, and high clearance rate. As an energy storage material, metal hydrides have been extensively studied and used in transporting hydrogen as clean energy, which can achieve a high hydrogen load and controlled hydrogen release. Considering the antioxidant properties of hydrogen and the delivery ability of metal hydrides, metal-hydride-based disease treatment strategies have attracted widespread attention. Up to now, metal hydrides have been reported for the treatment of tumors and a range of inflammation-related diseases. However, limited by the insufficient investment, the use of metal hydrides in disease treatment still has many shortcomings, such as low targeting efficiency, limited therapeutic activity, and complex material preparation process. Particularly, metal hydrides have been found to have a series of optical, acoustic, and catalytic properties when scaled up to the nanoscale, and these properties are also widely used to promote disease treatment effects. From this new perspective, we comprehensively summarize the very recent research progress on metal-hydride-based disease treatment in this review. Ultimately, the challenges and prospects of such a burgeoning cancer theranostics modality are outlooked to provide inspiration for the further development and clinical translation of metal hydrides.